Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Update

by · The Cerbat Gem

Enzo Biochem, Inc. (NYSE:ENZ – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Based on an average trading volume of 74,600 shares, the short-interest ratio is presently 6.9 days. Approximately 1.4% of the company’s stock are short sold.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Enzo Biochem stock. Renaissance Technologies LLC increased its position in Enzo Biochem, Inc. (NYSE:ENZ – Free Report) by 2.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,499,546 shares of the medical research company’s stock after acquiring an additional 64,417 shares during the quarter. Renaissance Technologies LLC owned about 4.86% of Enzo Biochem worth $2,725,000 at the end of the most recent quarter. 36.90% of the stock is currently owned by institutional investors.

Enzo Biochem Price Performance

NYSE ENZ remained flat at $1.13 during trading on Thursday. The company’s stock had a trading volume of 25,716 shares, compared to its average volume of 96,630. Enzo Biochem has a one year low of $0.99 and a one year high of $1.50. The business’s 50 day simple moving average is $1.12 and its two-hundred day simple moving average is $1.12.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a report on Monday. They set a “hold” rating on the stock.

Check Out Our Latest Stock Report on Enzo Biochem

About Enzo Biochem

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

See Also